Literature DB >> 2787515

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.

J M Cleghorn1, E S Garnett, C Nahmias, G Firnau, G M Brown, R Kaplan, H Szechtman, B Szechtman.   

Abstract

Frontal and parietal lobe metabolism was measured by [18F] fluorodeoxyglucose positron emission tomography in 8 never-medicated DSM-III schizophrenic patients and in 10 control subjects. Patients were in a psychotic episode at the time of this scan. Seven of eight had been ill less than 2 years and had only mild neurocognitive impairment. Frontal lobe glucose metabolism was significantly greater in schizophrenic patients than in controls. This finding differs from that of hypofrontality reported in chronic patients previously treated with neuroleptics. Relative glucose metabolism in the interior parietal lobe was significantly lower in schizophrenic patients than in controls. The frontal/parietal ratios were significantly greater in patients than in controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787515     DOI: 10.1016/0165-1781(89)90040-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

Review 1.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 3.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

4.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

5.  A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity.

Authors:  Se Joon Choi; Jun Mukai; Mirna Kvajo; Bin Xu; Anastasia Diamantopoulou; Pothitos M Pitychoutis; Bin Gou; Joseph A Gogos; Hui Zhang
Journal:  Cereb Cortex       Date:  2018-06-01       Impact factor: 5.357

Review 6.  Functional neuroimaging in psychiatry.

Authors:  C H Fu; P K McGuire
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

7.  A test-retest study of cerebral blood flow during somatosensory stimulation in depressed patients with schizophrenia and major depression.

Authors:  D Ebert; H Feistel; A Barocka; W Kaschka; T Mokrusch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia.

Authors:  K P Ebmeier; S M Lawrie; D H Blackwood; E C Johnstone; G M Goodwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

9.  Brain mechanisms of hallucinogens and entactogens.

Authors:  F X Vollenweider
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

10.  Neural models of schizophrenia.

Authors:  S Heckers
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.